[273 Pages Report] The pharmaceutical excipients market was valued at USD 6.07 Billion in 2017 and is expected to reach USD 8.53 Billion by 2023, at a CAGR of 5.9% during the forecast period.

The growing pharmaceutical market along with the advancements in functional excipients, growing generics market propelled by the patent cliffs, and the rapidly growing biopharmaceuticals sector are the major factors driving the growth of the market. Factors such as the emergence of multifunctional & co-processed excipients, shifting focus of pharmaceutical manufacturing to emerging markets, and the growing biologics and biosimilars industry also present significant opportunities for the growth of excipients.

Years considered for this report:
2017 – Base Year
2018–2023 – Forecast Period

Download the PDF Brochure for More Details@ http://bit.ly/2O2Shy4

This market is highly fragmented with the presence of many local, regional, and global players. Various small and medium-sized players operating in both developed and emerging markets are making this a highly competitive market. The companies in this market are mainly focusing on expansions and acquisitions to strengthen their product offerings and establish a strong geographical foothold. In 2017, the market is primarily dominated by DowDuPont (US), Roquette (France), Ashland (US), and BASF (Germany).

DowDuPont dominated the pharmaceutical excipients market in 2017. The company brings together the complementary portfolios of Dow and DuPont, making it one of the world’s largest chemical corporation. The acquisition of FMC’s Health & Nutrition business in November 2017 alleviated the company’s position in the global pharmaceutical excipients market bringing an extensive range of products under one roof. The company offers a comprehensive portfolio of excipients ranging from rheology modifiers, tablet coatings, controlled release, stabilizers, solubilizers, binding agents, and masking agents to name a few.

The company is largely known for its diversified cellulose compound offerings for the pharmaceutical industry. Its position among the top pharmaceutical excipient manufacturers is attributed to its global footprint through distributors and agents. The company is highly focused on conducting strategic agreements and expansions of its functional units. For instance, in December 2015, The Dow Chemical Company entered into a definitive agreement to acquire full ownership of Dow Corning Corporation (US).

Under the terms of the agreement, Dow will become the owner of Dow Corning which currently is a 50:50 joint venture between Dow Chemical Company and Dow Corning Inc. (US). The company also pursues the strategy of agreements and partnerships with well-known science and technology universities to enhance its presence in the pharmaceutical excipients market. The company intends to strengthen its presence in the market by delivering superior solutions and choices to customers. The firm strongly believes that investments in R&D offer great potential for short and long-term growth.

Roquette is the second-largest market player in the pharmaceutical excipients market. This is mainly attributed to its exhaustive portfolio of diluents, binders, coatings agents, sweeteners, and dispersants. This company is growing at a rapid pace in this market, by adopting various organic and inorganic growth strategies. In line with this, Roquette acquired Co Itacel, the excipient division of Blanver in Brazil in September 2017. This acquisition positively impacted the company’s revenue and increased its market presence in the North and Latin American regions. The company also launched new excipients in the market in January 2018, along with three new excipient brands in March 2017.

The company has a strong presence in the European region which is one of the major markets for its pharmaceutical excipients. Additionally, the firm also focuses on expanding its business globally to further strengthen its position in the market. For this, it aims to expand its business in high-growth regions such as Asia Pacific and Latin America.

You Can Also Request for the Customized Information as per Your Request@ http://bit.ly/2CDuQJX

Some of the other players competing in this market are Ashland (US), BASF (Germany), Kerry Group (Ireland), Evonik (Germany), Associated British Foods (UK), Archer Daniels Midland Company (US), Lubrizol (US), Croda (UK), Innophous Holdings (US), WACKER CHEMIE (Germany), and Signet (India).

Target Audience:

• Pharmaceutical excipient manufacturers
• Distributors and suppliers of pharmaceutical excipients
• Research and development (R&D) companies
• Drug manufacturers
• Drug suppliers and distributors
• Pharmaceutical/medical associations